Evidence Level
Slippery elm is a traditional demulcent known for its ability to soothe mucosal surfaces in the gastrointestinal tract. Its primary mechanism involves the formation of a protective gel by mucilage polysaccharides, which helps reduce irritation and inflammation (Watts et al., 2012). The U.S. Food and Drug Administration recognizes slippery elm as safe and effective for use as a demulcent to alleviate throat irritation.
Clinical evidence supporting its efficacy is limited, with most studies being empirical or small-scale. Langmead et al. (2002) demonstrated that slippery elm exhibits antioxidant effects comparable to aminosalicylates in reducing colonic inflammation, suggesting potential benefits for conditions like inflammatory bowel disease (IBD). However, more recent research has yielded mixed results. Tinsley et al. (2019) conducted a double-blind, randomized, placebo-controlled trial with 22 participants and found no beneficial effects of a detoxification supplement containing slippery elm on body composition, waist circumference, gastrointestinal symptoms, or blood markers in healthy adult females.
Despite the limited clinical evidence, slippery elm is often recommended as a complementary therapy for managing symptoms of GERD and IBD. Its traditional use and mechanistic understanding continue to support its role in soothing mucosal surfaces and reducing inflammation.